My Quote Request
6505-01-207-8898
20 Products
VIOGEN-C CAPS
MULTIVITAMIN AND MINERAL CAPSULES
NSN, MFG P/N
6505012078898
NSN
6505-01-207-8898
VIOGEN-C CAPS
MULTIVITAMIN AND MINERAL CAPSULES
NSN, MFG P/N
6505012078898
NSN
6505-01-207-8898
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS ASCORBIC ACID ACTIVE INGREDIENT AND 5.000 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE INGREDIENT AND 80.000 MILLIGRAMS ZINC SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTH:20.000 MILLIGRAMS OF CALCIUM PANTOTHENATE ACTIVE INGREDIENTS;50.000 MILLIGRAMS OF MAGNESIUM SULFATE ACTIVE INGREDIENTS;100.000 MILLIGRAMS OF NICOTINAMIDE ACTIVE INGREDIENTS;20.000 MILLIGRAMS OF THIAMINE ACTIVE
~1: INGREDIENTS
Related Searches:
ALCON BSS
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012078899
NSN
6505-01-207-8899
ALCON BSS
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012078899
NSN
6505-01-207-8899
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.048 PERCENTAGE, W/V CALCIUM CHLORIDE ACTIVE INGREDIENT AND 0.030 PERCENTAGE, W/V MAGNESIUM CHLORIDE ACTIVE INGREDIENT AND 0.075 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.390 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.640
ADMINISTRATION: INTRAOCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
~1: PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 0.170 PERCENTAGE, W/V SODIUM CITRATE ACTIVE INGREDIENT
Related Searches:
NDC00065-0795-30
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012078899
NSN
6505-01-207-8899
NDC00065-0795-30
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012078899
NSN
6505-01-207-8899
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.048 PERCENTAGE, W/V CALCIUM CHLORIDE ACTIVE INGREDIENT AND 0.030 PERCENTAGE, W/V MAGNESIUM CHLORIDE ACTIVE INGREDIENT AND 0.075 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.390 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.640
ADMINISTRATION: INTRAOCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
~1: PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 0.170 PERCENTAGE, W/V SODIUM CITRATE ACTIVE INGREDIENT
Related Searches:
NDC24208-0605-66
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012078899
NSN
6505-01-207-8899
NDC24208-0605-66
OPHTHALMIC IRRIGATING SOLUTION
NSN, MFG P/N
6505012078899
NSN
6505-01-207-8899
MFG
PHARMAFAIR INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.048 PERCENTAGE, W/V CALCIUM CHLORIDE ACTIVE INGREDIENT AND 0.030 PERCENTAGE, W/V MAGNESIUM CHLORIDE ACTIVE INGREDIENT AND 0.075 PERCENTAGE, W/V POTASSIUM CHLORIDE ACTIVE INGREDIENT AND 0.390 PERCENTAGE, W/V SODIUM ACETATE ACTIVE INGREDIENT AND 0.640
ADMINISTRATION: INTRAOCULAR
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
~1: PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT AND 0.170 PERCENTAGE, W/V SODIUM CITRATE ACTIVE INGREDIENT
Related Searches:
NDC00264-1141-01
ELECTROLYTE AND DEX
NSN, MFG P/N
6505012079930
NSN
6505-01-207-9930
MFG
B BRAUN MEDICAL INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH LITER CONTAINS CALCIUM ION 9MEQ,CHLORIDE ION 32 MEQ,GLUCONATE ION 4.2 MEQ,MAGNESIUM ION 16 MEQ,SODIUM ION 32 MEQ,AND SULFATE ION 16 MEQ; PARTIAL FILL 500 ML IN 1000 ML GLASS INFUSION BOTTLE W/HANGING DEVICE; CASE OF 6
Related Searches:
9794-01
FAT EMULSION INJECTION
NSN, MFG P/N
6505012081047
NSN
6505-01-208-1047
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.2% W/V EGG PHOSPHATIDES ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: WITH ADMINISTRATION SET
Related Searches:
LIPOSYN II 10%
FAT EMULSION INJECTION
NSN, MFG P/N
6505012081047
NSN
6505-01-208-1047
LIPOSYN II 10%
FAT EMULSION INJECTION
NSN, MFG P/N
6505012081047
NSN
6505-01-208-1047
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.2% W/V EGG PHOSPHATIDES ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: WITH ADMINISTRATION SET
Related Searches:
NDC00074-9794-01
FAT EMULSION INJECTION
NSN, MFG P/N
6505012081047
NSN
6505-01-208-1047
NDC00074-9794-01
FAT EMULSION INJECTION
NSN, MFG P/N
6505012081047
NSN
6505-01-208-1047
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V SAFFLOWER OIL ACTIVE INGREDIENT AND 5.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT AND 1.2% W/V EGG PHOSPHATIDES ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, INFUSION
SPECIAL FEATURES: WITH ADMINISTRATION SET
Related Searches:
253-198
BARIUM SULFATE FOR SUSPENSION,MODIFIED
NSN, MFG P/N
6505012082174
NSN
6505-01-208-2174
253-198
BARIUM SULFATE FOR SUSPENSION,MODIFIED
NSN, MFG P/N
6505012082174
NSN
6505-01-208-2174
MFG
LAFAYETTE PHARMACAL DIV OF ALCON LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, SOLUBLE
FLAVOR: FRUIT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00005-3865-61
PENICILLIN V POTASSIUM TABLETS,USP
NSN, MFG P/N
6505012082175
NSN
6505-01-208-2175
NDC00005-3865-61
PENICILLIN V POTASSIUM TABLETS,USP
NSN, MFG P/N
6505012082175
NSN
6505-01-208-2175
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 400000.000 UNITS PENICILLIN V POTASSIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 40.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: LEDERLE LABS. DIV.
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
MAALOX TC TABLET
ALUMINA AND MAGNESIA TABLETS,USP
NSN, MFG P/N
6505012083373
NSN
6505-01-208-3373
MAALOX TC TABLET
ALUMINA AND MAGNESIA TABLETS,USP
NSN, MFG P/N
6505012083373
NSN
6505-01-208-3373
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS ALUMINUM HYDROXIDE ACTIVE INGREDIENT AND 60.000 MILLIGRAMS MAGNESIUM HYDROXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
PRIMARY CONTAINER CONTENT QUANTITY: 48.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
Related Searches:
NDC00067-0344-48
ALUMINA AND MAGNESIA TABLETS,USP
NSN, MFG P/N
6505012083373
NSN
6505-01-208-3373
NDC00067-0344-48
ALUMINA AND MAGNESIA TABLETS,USP
NSN, MFG P/N
6505012083373
NSN
6505-01-208-3373
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 120.000 MILLIGRAMS ALUMINUM HYDROXIDE ACTIVE INGREDIENT AND 60.000 MILLIGRAMS MAGNESIUM HYDROXIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL, CHEWABLE
PRIMARY CONTAINER CONTENT QUANTITY: 48.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:COMPRESSION
Related Searches:
NDC00173-0362-38
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012085955
NSN
6505-01-208-5955
NDC00173-0362-38
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012085955
NSN
6505-01-208-5955
MFG
AMERISOURCEBERGEN DRUG CORPORATION DIV CORPORATE OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 2ML SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ZANTAC
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012085955
NSN
6505-01-208-5955
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 2ML SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ZANTAC INJECTION
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012085955
NSN
6505-01-208-5955
ZANTAC INJECTION
RANITIDINE INJECTION,USP
NSN, MFG P/N
6505012085955
NSN
6505-01-208-5955
MFG
GLAXO WELLCOME INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS RANITIDINE EQUIVALENT PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: RANITIDINE INJECTION USP 25MG/ML 2ML SINGLE DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00070-2341-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
NDC00070-2341-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
MFG
USV PHARMACEUTICAL CORP DIV OF WILLIAM H RORER INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.2489 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.50 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0104 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1875 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 125MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RORER PHARMACEUTICAL CORPORATION
Related Searches:
NDC00075-1355-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
NDC00075-1355-00
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
MFG
AVENTIS PHARMACEUTICALS PRODUCTS INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.2489 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.50 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0104 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1875 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 125MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RORER PHARMACEUTICAL CORPORATION
Related Searches:
NDC00258-3638-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
NDC00258-3638-01
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
MFG
INWOOD LABORATORIES INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.2489 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.50 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0104 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1875 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 125MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RORER PHARMACEUTICAL CORPORATION
Related Searches:
NDC00603-5950-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
NDC00603-5950-21
THEOPHYLLINE EXTENDED-RELEASE CAPSULES,USP
NSN, MFG P/N
6505012085993
NSN
6505-01-208-5993
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.2489 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 24
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 4.50 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0104 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1875 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 125MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: RORER PHARMACEUTICAL CORPORATION
Related Searches:
NDC00085-0752-05
LABETALOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012085995
NSN
6505-01-208-5995
NDC00085-0752-05
LABETALOL HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012085995
NSN
6505-01-208-5995
MFG
SCHERING LABORATORIES INSTITUTIONAL SALES DEPT K-11-3 L-5
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS LABETALOL HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LABETALOL HCL TABLETS 200MG 500S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE